GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » Scaled Net Operating Assets

QUIA PHARMA AB (OSTO:QUIA) Scaled Net Operating Assets : 0.76 (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

QUIA PHARMA AB's operating assets for the quarter that ended in Jun. 2024 was kr39.99 Mil. QUIA PHARMA AB's operating liabilities for the quarter that ended in Jun. 2024 was kr7.89 Mil. QUIA PHARMA AB's Total Assets for the quarter that ended in Dec. 2023 was kr41.96 Mil. Therefore, QUIA PHARMA AB's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.76.


QUIA PHARMA AB Scaled Net Operating Assets Historical Data

The historical data trend for QUIA PHARMA AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB Scaled Net Operating Assets Chart

QUIA PHARMA AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 -0.18 0.61 0.65 1.53

QUIA PHARMA AB Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.49 0.73 1.46 0.77

Competitive Comparison of QUIA PHARMA AB's Scaled Net Operating Assets

For the Biotechnology subindustry, QUIA PHARMA AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QUIA PHARMA AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's Scaled Net Operating Assets falls into.



QUIA PHARMA AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

QUIA PHARMA AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(41.858-6.097)/23.442
=1.53

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=41.959 - 0.101
=41.858

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=26.708 - 0 - 20.611
=6.097

QUIA PHARMA AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Dec. 2023 )
=(39.988-7.89)/41.959
=0.76

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=42.566 - 2.578
=39.988

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QUIA PHARMA AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


QUIA PHARMA AB Business Description

Industry
Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines